G Corvi

3.5k total citations
12 papers, 153 citations indexed

About

G Corvi is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G Corvi has authored 12 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Analytical Chemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G Corvi's work include Inflammatory mediators and NSAID effects (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). G Corvi is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). G Corvi collaborates with scholars based in Italy. G Corvi's co-authors include L. M. Fuccella, E. Moro, V. Tamassia, V. Mandelli, Franco Conti, Elena Tremoli, G. Bianchi Porro, Nicola Ragni, Giuseppe Mascellani and M Sirtori and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology and The Journal of Clinical Pharmacology.

In The Last Decade

G Corvi

12 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Corvi Italy 9 91 48 45 32 25 12 153
G Sacchetti Italy 11 118 1.3× 21 0.4× 75 1.7× 16 0.5× 35 1.4× 41 286
G Betzien Germany 9 58 0.6× 107 2.2× 38 0.8× 47 1.5× 6 0.2× 19 288
DA Richards United States 10 64 0.7× 153 3.2× 104 2.3× 24 0.8× 35 1.4× 21 367
CR Kumana Hong Kong 11 45 0.5× 101 2.1× 44 1.0× 58 1.8× 38 1.5× 36 354
Brigitte Lecocq France 9 40 0.4× 127 2.6× 50 1.1× 31 1.0× 20 0.8× 15 325
Edmund Sonnenblick United States 8 30 0.3× 181 3.8× 79 1.8× 21 0.7× 34 1.4× 10 353
J. G. Riddell United Kingdom 9 55 0.6× 161 3.4× 34 0.8× 59 1.8× 29 1.2× 17 321
G. Schröder Sweden 8 56 0.6× 106 2.2× 58 1.3× 16 0.5× 8 0.3× 24 360
DJ Sumner United Kingdom 11 54 0.6× 138 2.9× 43 1.0× 84 2.6× 12 0.5× 14 357
William Winters United States 5 35 0.4× 29 0.6× 22 0.5× 21 0.7× 8 0.3× 7 324

Countries citing papers authored by G Corvi

Since Specialization
Citations

This map shows the geographic impact of G Corvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Corvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Corvi more than expected).

Fields of papers citing papers by G Corvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Corvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Corvi. The network helps show where G Corvi may publish in the future.

Co-authorship network of co-authors of G Corvi

This figure shows the co-authorship network connecting the top 25 collaborators of G Corvi. A scholar is included among the top collaborators of G Corvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Corvi. G Corvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tremoli, Elena, P. Maderna, M Sirtori, et al.. (1981). Indobufen treatment in type iia hypercholesterolemic subjects: Effects on platelet function and malondialdehyde production. Pharmacological Research Communications. 13(9). 847–859. 5 indexed citations
2.
Vittoria, A, et al.. (1981). Inhibition of Platelet Aggregation in Man by Indobufen (K 3920). Journal of International Medical Research. 9(1). 12–17. 6 indexed citations
3.
Corradi-Perini, Carla, et al.. (1981). Prevention of in vivo Platelet Aggregation by Indobufen in Angina Patients during Exercise. Journal of International Medical Research. 9(2). 113–119. 2 indexed citations
4.
Corvi, G, et al.. (1981). Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).. PubMed. 66(2). 160–70. 9 indexed citations
6.
Fuccella, L. M., et al.. (1979). Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man. European Journal of Clinical Pharmacology. 15(5). 323–327. 23 indexed citations
7.
Fuccella, L. M., et al.. (1977). Application of Nonparametric Procedure for Bioassay Data to the Evaluation of Analgesics in Man. The Journal of Clinical Pharmacology. 17(4). 177–185. 18 indexed citations
8.
Corvi, G, et al.. (1977). Effect of food on absorption of indoprofen administered orally to man in two dosage forms.. PubMed. 15(8). 389–93. 8 indexed citations
9.
Caruso, I, et al.. (1977). Pharmacokinetic studies of indoprofen in healthy volunteers and in patients.. PubMed. 15(9). 411–6. 10 indexed citations
10.
Porro, G. Bianchi, et al.. (1977). Gastro-Intestinal Blood Loss during Administration of Indoprofen, Aspirin and Ibuprofen. Journal of International Medical Research. 5(3). 155–160. 14 indexed citations
11.
Tamassia, V., et al.. (1976). Pharmacokinetics and bioavailability of indoprofen in man. European Journal of Clinical Pharmacology. 10(3-4). 257–262. 14 indexed citations
12.
Fuccella, L. M., et al.. (1975). Double‐blind study of the analgesic effect of indoprofen (K 4277). Clinical Pharmacology & Therapeutics. 17(3). 277–283. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026